Our Privacy Notice outlines how ViiV Healthcare handles the processing of personal information when dealing with your enquiry, complaint or adverse event report.

Thank you for choosing to report a suspected adverse event​

For Belgium: Please report adverse events to the Belgian Centre for Pharmacovigilance for medicines for Human use of the Federal Agency for Medicines and Health Products via or via or to ViiV HealthCare srl/bvba 010/ 85 65 00.

For Luxembourg: Please report adverse events to the Centre Régional de Pharmacovigilance de Nancy or to the Division de la Pharmacie et des Médicaments, Direction de la Santé à Luxembourg or to ViiV Healthcare srl/bvba +32 10 85 65 00.

PM-BE-HVX-WCNT-220004 - May 2022